CD44 and breast carcinoma: Wright et al. (19) reported that BRCA1-deficient mouse mammary tumors—which mimic the BRCA1-associated breast cancer—harbor heterogeneous BCSCs subpopulations including CD133+ (prominin1) and CD44+/CD24− stem cells.